Novel fumarate salts of a histamine H3 receptor antagonist

Details for Australian Patent Application No. 2010264422 (hide)

Owner Sanofi

Inventors Langevin, Beverly C.; Farr, Robert Allan; Shah, Dinubhai H.; Sherer, Daniel

Agent Watermark

Pub. Number AU-A-2010264422

PCT Pub. Number WO2010/151611

Priority 0959110 17.12.09 FR; 61/220,683 26.06.09 US

Filing date 24 June 2010

Wipo publication date 29 December 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4725 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/151611 Priority application(s): WO2010/151611

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010264424-Low mass solid oxide fuel device array monolith

2010264417-Systems and methods for harvesting algae from photobioreactors